RSS Feeds
Search

Deals review

Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Related deals

Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG

Nabi Biopharmaceuticals Acquires Full Rights to Aloprimâ„¢

Akzo Nobel's Diosynth Biotechnology and Human Genome Sciences sign antibody manufacturing agreement

Nabi Biopharmaceuticals Announces Arbitration Settlement With Inhibitex, Inc.

Cobra signs long term deal with Neovacs SA to supply Phase I clinical trial material for a novel protein active immunization therapy-TNFa Kinoid

Nabi Biopharmaceuticals signs international distribution agreement for Nabi-HB(R)

Pharming And Diosynth Biotechnology Sign Manufacturing Agreement For Rec Human C1 Inhibitor

Akzo Nobel unit signs deal with Pfizer

Nabi Biopharmaceuticals Takes Steps to Expand Market Potential for StaphVAX® Beyond ESRD Patient Population

Diosynth Biotechnology Announces Agreement with Pfizer

More deals

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us